Tryn T. Stimart Esq., J.D.
Net Worth
Last updated:
What is Tryn T. Stimart Esq., J.D. net worth?
The estimated net worth of Mr. Tryn T. Stimart Esq., J.D. is at least $28,679,225 as of 9 Jun 2021. He owns shares worth $1,075 as insider, has earned $25,500,000 from insider trading and has received compensation worth at least $3,178,150 in AbCellera Biologics Inc..
What is the salary of Tryn T. Stimart Esq., J.D.?
Mr. Tryn T. Stimart Esq., J.D. salary is $635,630 per year as Chief Legal Officer, Chief Compliance Officer & Corporation Sec. in AbCellera Biologics Inc..
How old is Tryn T. Stimart Esq., J.D.?
Mr. Tryn T. Stimart Esq., J.D. is 55 years old, born in 1970.
What stocks does Tryn T. Stimart Esq., J.D. currently own?
As insider, Mr. Tryn T. Stimart Esq., J.D. owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| AbCellera Biologics Inc. (ABCL) | Chief Legal Officer, Chief Compliance Officer & Corporation Sec. | 250 | $4.3 | $1,075 |
What does AbCellera Biologics Inc. do?
AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in progress, or under contract with 36 partners. AbCellera Biologics Inc. has a research collaboration and license agreement with Eli Lilly and Company. The company was incorporated in 2012 and is headquartered in Vancouver, Canada.
Tryn T. Stimart Esq., J.D. insider trading
AbCellera Biologics Inc.
Mr. Tryn T. Stimart Esq., J.D. has made only one insider trade between 2020-2021, according to the Form 4 filled with the SEC. He sold 1,000,000 units of ABCL stock worth $25,500,000 on 9 Jun 2021.
As of 9 Jun 2021 he still owns at least 250 units of ABCL stock.
AbCellera Biologics key executives
AbCellera Biologics Inc. executives and other stock owners filed with the SEC:
- Dr. Carl L.G. Hansen Ph.D. (51) Chief Executive Officer, Pres & Chairperson
- Dr. Veronique Lecault Ph.D. (40) Chief Operating Officer & Director
- Mr. Tryn T. Stimart Esq., J.D. (55) Chief Legal Officer, Chief Compliance Officer & Corporation Sec.